bankruptcy

New On The Block Following a review of strategic alternatives initiated earlier this year, Domo, Inc. (NASDAQ:DOMO) said its board has determined that pursuing a strategic transaction is the most effective path to maximize shareholder value. • Domo stock is showing exceptional strength. What...

New On The Block Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, announced that, after extensive consideration of the company's pipeline and financial resources, it has retained Raymond James as its financial advisor to assist in evaluating a full range of strategic...

Strategy Inc. (NASDAQ:MSTR) may not be having the best of times, but cryptocurrency punters still view the prospect of the Bitcoin (CRYPTO: BTC) hoarding giant going bankrupt as unlikely. Is Strategy Safe? Traders on Polygon (CRYPTO: POL)-based Polymarket assigned a 10% chance to Strategy...

New On The Block Jasper Therapeutics (NASDAQ:JSPR), a clinical-stage biotechnology company, is reviewing strategic alternatives, including a sale or merger, to maximize shareholder value. The company intends to evaluate cost-saving measures to preserve cash and maintain compliance with regulatory...

Sen. Bill Cassidy (R-La.) urged President Donald Trump to address the issue of rising medical debt. During a Senate floor speech on Wednesday, Cassidy revealed that 60% of personal bankruptcies are due to medical bills. He noted that monthly costs are increasing for the...

New On The Block Largo Inc. (NASDAQ:LGO) plans to evaluate strategic alternatives for its 100%-owned tungsten assets. The evaluation process is expected to include joint ventures, asset-level financing, minority investments, sale or spin-out opportunities to unlock value for Largo shareholders...

Updates From The Block NextEra Energy (NYSE:NEE) is planning to buy Dominion Energy (NYSE:D) for $66.8 billion. The all-stock transaction, which is pending regulatory approval, will be the third-largest energy company behind Exxon and Chevron. The combined enterprise value is approximately $420...

New On The Block GoPro (NASDAQ:GPRO) has retained Houlihan Lokey as financial adviser and Fenwick & West as legal counsel as it explores a potential sale and other strategic alternatives. The company previously disclosed that it had launched a review process following multiple unsolicited...

New On The Block Popular peanut butter and jelly brand J.M. Smucker (NYSE:SJM) hired Goldman Sachs to conduct a strategic review of its portfolio, sources told Axios Pro. As activist investor Elliott Investment Management ramped up pressure on Smucker, the company was reportedly weighing options...

New On The Block Cigna CEO Brian Evanko stated that the insurer is exploring strategic options for eviCore, which manages medical claims and reviews prior authorization requests. Cigna also plans to stop selling health insurance plans to individuals starting in 2027, as the company “aims to...

New On The Block Rayonier Advanced Materials Inc. (NYSE:RYAM) is in the formal process of exploring strategic alternatives to maximize shareholder value. The company has hired Morgan Stanley as its financial advisor and Wachtell, Lipton, Rosen & Katz as its legal counsel in the process....

New On The Block Polypeptide Group has announced it is conducting a review of strategic alternatives, including potential partnerships or a sale. The process, which is in coordination with majority shareholder Draupnir Holding B.V., is aimed at enhancing the company's value amid reports from...

New On The Block Playtika Holding Corp. (NASDAQ:PLTK)) is conducting a review and reevaluation of strategic alternatives across its portfolio to enhance shareholder value. The mobile gaming entertainment company tapped Morgan Stanley as financial advisor. Jorey Chernett delivered a letter to...

New On The Block Kanen Wealth Management has urged the board of Xponential Fitness to “immediately initiate and publicly announce” a formal review of strategic alternatives, including the sale of the company. After speaking with investors and the company’s “prolonged...

New On The Block ENDRA Life Sciences' board initiated a sales process to evaluate a range of strategic alternatives to maximize shareholder value. The company has engaged Lucid Capital Management as its financial advisor and K&L Gates as its legal counsel. ENDRA has not set a timeline for the...